U.S. Medical Robotics Market Hits $33.26B by 2035

Market Outlook

By 2035, the U.S. Medical Robotics Market is expected to reach approximately USD 33.26 billion, expanding at a CAGR of 15.10% during the forecast period 2026–2035. The market was valued at an estimated USD 8.15 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. medical robotics industry is transitioning from a concentrated surgical-equipment category into a broader clinical technology ecosystem encompassing robotic-assisted surgery, orthopedic and spinal robotics, endoluminal intervention, robotic radiosurgery, rehabilitation robotics, assistive exoskeletons, microsurgery systems, robotic hospital automation, and the recurring instruments, software, analytics, and service contracts attached to these platforms.

Market expansion is being supported by increasing minimally invasive procedure volumes, the aging U.S. population, surgeon and nursing workforce constraints, demand for more reproducible procedural outcomes, rapid growth in joint replacement and cancer surgery, and rising hospital interest in digitally connected operating rooms. Approximately 61.2 million people in the United States were aged 65 or older in 2024. This population requires disproportionately more orthopedic, urologic, oncologic, gynecologic, cardiovascular, neurologic, and rehabilitation services, creating a durable procedure base for medical robotics.

The U.S. provider environment offers substantial commercial scale. The country has approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and over 35 million annual hospital admissions. Hospital care spending exceeded USD 1.63 trillion in 2024 and was projected to approach USD 1.8 trillion in 2025. Within this environment, robotics is increasingly treated as a service-line investment rather than an isolated equipment purchase. Health systems assess whether a platform can strengthen surgeon recruitment, retain profitable procedures, increase operating-room utilization, support minimally invasive surgery, reduce variability, improve patient experience, and protect regional referral share.

The historical market expanded from approximately USD 4.78 billion in 2021 to USD 7.10 billion in 2024. Estimated values reached USD 5.41 billion in 2022 and USD 6.16 billion in 2023. Early historical growth was supported by the normalization of elective surgery after pandemic-related disruption, expansion of robotic general surgery beyond urology, increased penetration of orthopedic robotic systems, and recovery in hospital capital spending. Growth accelerated in 2024 and 2025 as health systems began replacing earlier-generation robotic platforms and evaluating modular, single-port, outpatient-oriented, and data-enabled alternatives.

The market estimate includes robotic systems, procedure-specific instruments and accessories, software, maintenance, training, analytics, robotic rehabilitation equipment, assistive medical robots, and clinically integrated hospital robotic solutions. Conventional laparoscopic equipment, independent surgical navigation without robotic actuation, industrial robots used in device manufacturing, and general-purpose artificial intelligence software without a robotic clinical workflow are excluded.

Introduction

According to the U.S. Medical Robotics Market Report, medical robotics has become one of the most strategically important areas of capital investment in American healthcare. The category sits at the intersection of medical device engineering, digital surgery, imaging, artificial intelligence, clinical training, recurring consumables, and hospital service-line economics.

The market is not defined only by the sale of robotic hardware. A commercially successful platform typically creates a multi-year revenue relationship involving instruments, drapes, accessories, procedure planning, software upgrades, preventive maintenance, technical support, surgeon training, clinical education, data services, and workflow integration. As a result, the lifetime economic value of an installed system can be substantially greater than its initial purchase price.

The U.S. remains the most commercially influential market for medical robotics because of its large procedural base, high concentration of specialist surgeons, advanced hospital infrastructure, established medical-device reimbursement pathways, deep clinical-trial network, and willingness to fund premium technologies when they support measurable strategic or operational benefits. Academic medical centers often act as early evaluators, while large integrated delivery networks determine whether new platforms can scale across multiple hospitals.

Robotic-assisted surgery is currently the largest component of the market. Soft-tissue systems are used across urology, gynecology, general surgery, thoracic surgery, colorectal surgery, bariatric surgery, and selected head-and-neck procedures. Orthopedic and spine robots support preoperative planning, implant alignment, bone preparation, navigation, screw placement, and execution of patient-specific surgical plans. Endoluminal robots extend robotic control into bronchoscopy and urinary-tract procedures. Other categories include robotic radiosurgery, stereotactic neurosurgery, robotic microsurgery, rehabilitation systems, exoskeletons, and automated pharmacy or hospital logistics platforms.

The economics of adoption are becoming more demanding. Many hospitals already operate at least one established robotic platform, meaning the next purchasing cycle is increasingly about replacement, fleet expansion, procedural specialization, or competitive conversion. Procurement committees are therefore examining utilization per system, contribution margin per procedure, surgeon demand, room turnover, disposable cost, maintenance burden, compatibility with existing instruments, training requirements, cybersecurity, and the ability to support multiple specialties.

During 2026–2035, competition will shift from basic robotic capability toward platform economics. Hospitals will favor systems that can serve several procedures, integrate with imaging and digital operating-room infrastructure, generate useful procedural data, simplify training, and deliver predictable operating costs. Companies that depend on high capital prices without demonstrating utilization or recurring workflow value will face stronger resistance from financially constrained providers.

Key Market Drivers: What’s Fueling the U.S. Medical Robotics Market Boom?

The first major driver is the expansion of minimally invasive surgery. Patients, surgeons, hospitals, and payers increasingly prefer procedures that can reduce incision size, blood loss, postoperative pain, hospitalization, and recovery time when clinical outcomes are at least equivalent to open surgery. Robotic systems can offer magnified visualization, articulated instruments, tremor filtration, stable camera control, motion scaling, and access to confined anatomy. These capabilities have supported adoption in prostatectomy, hysterectomy, colectomy, hernia repair, bariatric surgery, thoracic resection, partial nephrectomy, and other complex procedures.

The second driver is the aging U.S. population. The country’s population aged 65 and older is expanding faster than the overall population and has reached more than 61 million people. Older adults account for a high proportion of joint replacements, cancer procedures, spinal interventions, urologic surgery, cardiac care, and rehabilitation utilization. This demographic pattern creates a sustained pipeline of procedures that can be addressed through soft-tissue robotics, orthopedic robotics, stereotactic systems, and robotic rehabilitation technologies.

A third driver is the large disease and procedure burden addressable through robotics. The United States recorded an estimated 313,780 new prostate cancer cases in 2025, supporting continued demand for robotic prostatectomy and related urologic procedures. Robotic platforms are also increasingly used in colorectal, gynecologic, kidney, lung, and selected head-and-neck cancer surgeries. In orthopedics, the American Joint Replacement Registry has captured more than four million hip and knee arthroplasty procedures from institutions across all 50 states, illustrating the scale of the procedural base available to robotic planning and execution systems.

A fourth driver is hospital competition for surgeons and procedural volume. High-performing robotic programs can help hospitals recruit specialists, retain cases that might otherwise migrate to competing systems, and position service lines as technologically advanced. In large metropolitan markets, the absence of a modern robotic platform can become a competitive disadvantage in urology, gynecology, joint replacement, spine surgery, and complex general surgery. This strategic pressure supports purchasing even when direct cost savings are difficult to prove.

A fifth driver is the operating-room workforce challenge. U.S. hospitals continue to face shortages and rising costs across nursing, anesthesia, sterile processing, biomedical engineering, and surgical support functions. Robotics does not remove the need for skilled teams, but well-designed systems can standardize selected steps, support more consistent execution, improve visualization, reduce dependence on manual instrument positioning, and generate procedural information that can be used for training and performance improvement. Platforms that simplify setup, docking, turnover, and troubleshooting will have an advantage over systems that increase staffing complexity.

A sixth driver is the expansion of robotics beyond flagship academic hospitals. Earlier robotic systems were concentrated in large tertiary centers with substantial capital budgets and high procedure volumes. New modular systems, smaller footprints, flexible financing structures, managed-service arrangements, leasing models, and procedure-based contracts are making robotics more accessible to community hospitals, specialty hospitals, and ambulatory surgery centers. The outpatient opportunity is particularly important in orthopedics, general surgery, gynecology, and selected urologic procedures.

A seventh driver is the growth of recurring instrument and accessory revenue. Robotic procedures require proprietary or platform-compatible instruments, accessories, drapes, imaging inputs, software, and technical support. As the installed base expands, recurring revenue can grow faster than new system placements. This economic model allows leading manufacturers to support clinical education and product development while creating high switching costs for hospitals.

An eighth driver is the emergence of competition in soft-tissue robotic surgery. For many years, the U.S. market was characterized by one dominant multi-specialty platform. The regulatory entry of Medtronic’s Hugo system, CMR Surgical’s Versius Plus, Distalmotion’s Dexter system, and Johnson & Johnson’s OTTAVA platform is changing hospital purchasing discussions. Additional competition can widen procedure access, increase financing flexibility, accelerate feature development, and create alternatives for hospitals concerned about vendor concentration.

A ninth driver is the connection between robotics and procedural data. Newer systems can capture information on instrument movement, force, case duration, workflow steps, energy use, video, and system performance. This data can support surgeon education, credentialing, quality improvement, maintenance forecasting, and future artificial-intelligence applications. Hospitals increasingly view the digital layer as a strategic asset, although its value depends on interoperability, data governance, clinical validation, and cybersecurity.

The final major driver is regulatory and clinical innovation density. The U.S. Food and Drug Administration provides established pathways for computer-assisted surgical systems while requiring manufacturers to define specific intended uses and demonstrate safety and effectiveness. The number of robotic platforms entering U.S. commercialization or indication-expansion programs increased materially during 2024–2026, strengthening competition across soft-tissue, orthopedic, endoluminal, and specialty robotic applications.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. medical robotics market is moving toward smaller footprints, multi-specialty flexibility, enhanced sensing, intelligent workflow support, and lower operational friction. The most valuable innovation is no longer robotic movement alone. Hospitals now expect new systems to improve the complete procedure pathway, from patient selection and planning to intraoperative execution, documentation, and postoperative review.

Force and tissue-interaction sensing represent an important development. Traditional robotic systems visually translate the surgeon’s movement but provide limited direct tactile feedback. Newer platforms are beginning to measure instrument forces and return useful information to the surgeon. These capabilities may help reduce excessive tissue force, support objective training, and create new data streams for procedural analytics. Their long-term value will depend on evidence showing that the information changes technique or improves clinical outcomes.

Single-port and reduced-port systems are expanding the range of robotic approaches. These platforms deploy multiple instruments through a limited access point and are being evaluated in urologic, colorectal, transanal, thoracic, and head-and-neck procedures. Their potential value includes fewer incisions, improved access to narrow anatomy, and differentiation for advanced surgical programs. However, adoption requires specialized training and may remain concentrated in high-volume centers until procedure economics become more widely established.

Modular robotic systems are also gaining attention. Instead of relying on a single fixed patient-side cart, modular architectures allow hospitals to configure arms around the operating table based on procedure type and room layout. This can improve flexibility but may create new setup and storage requirements. Hospitals will compare modularity against docking time, footprint, staffing needs, and the consistency of arm positioning.

Orthopedic robotics is evolving from a procedure-specific tool into a multi-application platform. Systems are expanding beyond partial knee and total knee replacement into total hip, shoulder, spine, and other musculoskeletal procedures. The strategic objective is to spread the capital cost across a larger procedural base while linking implants, imaging, planning software, navigation, and robotic execution within one ecosystem. Manufacturers with both robotic systems and implant portfolios can use this integration to influence hospital standardization.

Endoluminal robotics is opening new markets in pulmonary and urologic intervention. Robotic bronchoscopy platforms can provide controlled navigation to peripheral lung lesions, where conventional access may be difficult. Urologic endoluminal platforms are being developed for stone management and visualization within the urinary tract. These applications connect robotics with diagnostic imaging, biopsy, therapeutic intervention, and disposable devices, creating an attractive recurring-revenue model.

Artificial intelligence is increasingly being incorporated into workflow guidance, video management, segmentation, procedure planning, and performance analysis. Near-term AI adoption is likely to focus on practical functions such as identifying procedural steps, organizing video, improving image quality, flagging workflow delays, supporting training, and predicting equipment service requirements. Fully autonomous surgery remains a longer-term proposition because of regulatory, clinical, ethical, and liability requirements.

Robotic microsurgery is another emerging category. Systems designed to stabilize and scale fine hand movements can support lymphatic, reconstructive, vascular, and other microsurgical procedures. The addressable procedure base is smaller than general surgery or orthopedics, but the clinical value can be high because these procedures require exceptional precision and are limited by the availability of highly trained specialists.

Rehabilitation robotics and wearable exoskeletons are advancing through lighter materials, improved sensors, adaptive control algorithms, remote monitoring, and more individualized therapy programs. These systems can provide repetitive, measurable movement training for patients recovering from stroke, spinal cord injury, neurologic disease, or orthopedic trauma. Commercial adoption depends on reimbursement, therapist acceptance, patient selection, facility budgets, and proof that robotic therapy improves functional outcomes or staff productivity.

Manufacturers are also redesigning commercial models. Capital purchase remains common, but leasing, usage-based pricing, managed services, operating leases, placement agreements, and bundled instrument contracts are becoming more important. These models reduce the initial budget hurdle but can create long-term contractual obligations. Sophisticated health systems will evaluate total cost over the contract period rather than focusing only on the initial payment.

Segmentation Insights

The U.S. Medical Robotics Market is segmented on the basis of product and service, application, robotic modality, end user, and region.

By Product and Service

Robotic systems constitute the largest upfront capital component of the market. This segment includes surgeon consoles, robotic arms, patient-side carts, positioning equipment, vision systems, navigation units, planning workstations, robotic rehabilitation equipment, exoskeletons, and specialized robotic platforms. System demand is driven by new installations, fleet expansion, replacement of earlier generations, and the introduction of new procedure indications. Multi-specialty systems command significant strategic interest because they can distribute utilization across several service lines.
Instruments and accessories represent the fastest-expanding recurring category. The segment includes robotic forceps, scissors, staplers, needle drivers, energy instruments, burs, cutting tools, trackers, sterile drapes, scopes, cannulas, trocars, probes, catheters, disposable kits, and procedure-specific accessories. Growth is directly linked to procedure volume rather than system placements alone. Manufacturers with large installed bases and proprietary instrument ecosystems are positioned to generate predictable recurring revenue.
Software, services, maintenance, and training form an increasingly important component. Service contracts support uptime, preventive maintenance, technical support, system upgrades, and repair. Software supports imaging, surgical planning, navigation, analytics, video management, workflow analysis, and equipment monitoring. Training includes simulation, proctoring, credentialing support, clinical education, and team-based operating-room preparation. This segment is expected to gain value as robotic fleets become larger and more digitally connected.

By Application

General and digestive surgery represents one of the largest growth opportunities. The segment includes hernia repair, colorectal surgery, bariatric surgery, cholecystectomy, foregut procedures, and selected hepatobiliary operations. General surgery offers a larger potential procedure base than early robotic applications, but hospitals must achieve efficient setup and competitive disposable costs for broad adoption. Systems suited to multiple abdominal quadrants and varying patient anatomy will have an advantage.
Urology and gynecology remain foundational robotic applications. Robotic prostatectomy established the commercial relevance of soft-tissue surgery systems in the United States. Partial nephrectomy, cystectomy, hysterectomy, myomectomy, sacrocolpopexy, endometriosis surgery, and other pelvic procedures continue to support utilization. Urology is also becoming a major entry point for new competitors because procedure workflows are well understood and specialist demand for robotic capability is established.
Orthopedic and spine surgery is one of the fastest-growing application categories. Robotic-assisted total knee, partial knee, hip, shoulder, and spinal procedures are supported by high procedural volumes and growing demand for patient-specific planning. Hospitals evaluate whether robotics can improve alignment, implant positioning, reproducibility, surgical confidence, and data capture. Implant pull-through is central to the commercial model because robotic platforms can reinforce the use of a manufacturer’s associated implant portfolio.
Neurosurgery and robotic radiosurgery represent high-acuity, technology-intensive applications. Stereotactic robots can assist with biopsy, electrode placement, laser ablation, and other procedures requiring precise trajectory planning. Robotic radiosurgery systems deliver highly targeted radiation using image guidance and automated positioning. These systems are concentrated in tertiary hospitals, cancer centers, and academic institutions because they require specialist teams, advanced imaging, and significant capital investment.
Cardiothoracic, endoluminal, and interventional applications are emerging growth areas. Robotic platforms support selected thoracic and cardiac procedures, catheter navigation, bronchoscopy, and urinary-tract intervention. Robotic bronchoscopy is particularly important because of the need to diagnose small peripheral lung lesions. Cardiovascular robotic applications remain more specialized but may expand as systems improve navigation, stability, imaging integration, and catheter control.
Rehabilitation and assistive care applications include robotic gait therapy, upper-limb rehabilitation, exoskeleton-assisted movement, and robotic support for patients with neurologic or musculoskeletal impairment. The segment is smaller than surgical robotics by value but addresses a large population affected by stroke, spinal cord injury, traumatic injury, and age-related mobility loss. Expansion will depend on reimbursement and evidence demonstrating measurable functional improvement.

By Robotic Modality

Soft-tissue surgical robots dominate the market by revenue. These systems provide surgeon-controlled manipulation of articulated instruments under enhanced visualization. Multi-port systems account for the largest installed base, while single-port, reduced-port, modular, and open-console configurations are increasing competitive diversity. The segment benefits from recurring instruments and broad procedure expansion.
Orthopedic and spine robotic systems represent the second major modality. These platforms combine preoperative imaging, planning, navigation, tracking, and robotic guidance or execution. Their value proposition is closely tied to implant placement and surgical reproducibility. Competition is shifting toward systems that can support multiple joints or combine spine navigation and robotics within an integrated platform.
Endoluminal and catheter-based robots provide controlled navigation through natural anatomical pathways or the vascular system. Applications include robotic bronchoscopy, endourology, and selected cardiac interventions. These systems frequently create recurring revenue through catheters, scopes, probes, biopsy tools, and other disposable devices.
Rehabilitation robots and exoskeletons support repetitive therapeutic movement or assisted mobility. They are used in inpatient rehabilitation hospitals, outpatient therapy centers, research institutions, and selected home or community settings. Adoption is influenced by device cost, therapist workflow, patient eligibility, safety requirements, and payer coverage.
Hospital, pharmacy, and logistical robots automate selected non-surgical tasks such as medication preparation, transport, material movement, and telepresence. These systems can reduce manual handling and support workflow standardization, but the purchasing decision is generally based on labor economics and operational return rather than surgical revenue. Their contribution to the overall market will increase as hospitals seek automation solutions for persistent workforce constraints.

By End User

Hospitals and integrated health systems are the dominant end users. They account for most high-acuity robotic procedures and the largest share of capital investment. Large health systems increasingly negotiate enterprise agreements covering system placement, instruments, service, training, and analytics. Their value-analysis committees require evidence related to utilization, clinical outcomes, total cost, cybersecurity, and interoperability.
Academic medical centers and tertiary referral hospitals are critical early adopters. These institutions conduct clinical trials, evaluate investigational systems, generate real-world evidence, train surgeons, and introduce complex robotic procedures. Their adoption decisions influence broader market acceptance, but their clinical priorities may differ from those of community hospitals.
Ambulatory surgery centers represent a high-growth end-user category. The shift of eligible orthopedic, general surgical, gynecologic, and urologic procedures into outpatient settings is creating demand for compact systems, fast setup, efficient turnover, predictable consumable costs, and financing models suited to lower reimbursement environments. Robotics designed for an inpatient operating room may not automatically fit ASC workflow or economics.
Specialty hospitals and dedicated surgical centers are attractive users because they can concentrate procedure volumes and standardize teams. Orthopedic hospitals, cancer centers, women’s hospitals, urology centers, and spine institutes can achieve higher utilization than general hospitals if the robotic platform aligns with their procedure mix.
Rehabilitation hospitals, therapy networks, pharmacies, and research institutions form a smaller but strategically important user group. Rehabilitation providers purchase robotic therapy and exoskeleton systems, while pharmacy and hospital operations teams evaluate automation robots. Research institutions also support development in autonomous functions, human-machine interaction, surgical data science, and next-generation sensing.

Regional Insights: Where the Market Is Growing Fastest

The U.S. Medical Robotics Market is geographically segmented into the South, West, Northeast, and Midwest. Regional adoption varies according to population growth, surgical volume, hospital capital capacity, academic-center concentration, surgeon density, aging demographics, payer mix, ambulatory surgery penetration, medtech innovation activity, and the presence of high-volume orthopedic, oncology, urology, and general surgery programs.

The South represented the largest regional market in 2025, with an estimated value of USD 2.85 billion. The West accounted for approximately USD 2.12 billion, followed by the Northeast at USD 1.79 billion and the Midwest at USD 1.39 billion. The West is expected to record the fastest regional growth through 2035, while the South will retain the largest absolute revenue opportunity.

South

The South is the largest U.S. medical robotics market and is projected to expand from approximately USD 2.85 billion in 2025 to USD 11.75 billion by 2035. Growth will be supported by population migration, health-system expansion, large Medicare populations, high surgical demand, new hospital construction, and the continued development of regional orthopedic, oncology, urology, and general surgery centers.

Texas is the most important state market in the region. Houston, Dallas–Fort Worth, Austin, and San Antonio contain major academic hospitals, integrated delivery networks, cancer programs, orthopedic centers, and surgical training institutions. Texas combines high procedure volume with a competitive hospital environment, making robotic capability important for physician recruitment and referral capture. The state is also becoming a launch location for newer soft-tissue systems and outpatient robotic models.

Florida is another major demand center because of its large and rapidly expanding older population. Robotic prostatectomy, hysterectomy, joint replacement, spine surgery, colorectal surgery, thoracic surgery, and rehabilitation applications benefit from strong Medicare-linked demand. Health systems in Miami, Tampa, Orlando, Jacksonville, and South Florida increasingly operate multi-site robotic fleets and specialty programs.

North Carolina, Georgia, Tennessee, and Virginia have strong growth prospects. North Carolina benefits from academic medical centers, clinical research, and expanding health systems in the Research Triangle, Charlotte, and Winston-Salem. Georgia is supported by Atlanta’s hospital concentration and population growth. Tennessee has large provider organizations in Nashville, Memphis, and Knoxville, while Virginia combines sophisticated metropolitan systems with large regional referral networks.

Maryland, Delaware, and the District of Columbia form an innovation-intensive submarket with academic hospitals, federal health institutions, clinical research, and advanced cancer and surgical programs. Maryland has particular importance in image-guided intervention, neurosurgery, oncology, and clinical technology evaluation.

South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have smaller absolute markets but substantial unmet clinical need. Several of these states have high chronic disease burdens, rural populations, and uneven access to advanced surgery. Large referral hospitals will continue to purchase premium systems, while smaller providers may favor mobile, modular, shared-service, or regional hub-and-spoke models.

The primary constraint in the South is uneven capital capacity. Large metropolitan systems can sustain several robotic platforms, while rural and independent hospitals may struggle to achieve sufficient utilization. Vendors that offer flexible financing, clinical-program development, remote support, and structured surgeon training will be better positioned to penetrate these markets.

West

The West is projected to be the fastest-growing region, expanding from approximately USD 2.12 billion in 2025 to USD 9.65 billion by 2035. Regional growth will be driven by technology adoption, strong venture investment, high outpatient penetration, medtech development, population expansion in selected states, and demand for data-enabled clinical systems.

California dominates the regional market. The state combines a large population, major academic hospitals, integrated systems, cancer centers, innovation-oriented surgeons, medtech companies, artificial-intelligence developers, and digital-health infrastructure. The San Francisco Bay Area, Los Angeles, San Diego, Sacramento, and Orange County are important markets for soft-tissue robotics, robotic bronchoscopy, radiosurgery, spine robotics, orthopedic systems, and rehabilitation technology.

California is also strategically important because purchasing decisions made by large provider systems can influence national adoption. Providers frequently evaluate interoperability, environmental footprint, data governance, workforce impact, and equity of access in addition to procedural performance. However, high labor costs and pressure on hospital margins strengthen the requirement for measurable utilization and workflow value.

Washington and Oregon have sophisticated integrated delivery networks and high adoption of connected clinical technologies. Seattle and Portland support advanced surgical, oncology, orthopedic, and research programs. These states are attractive for software-enabled robotics and enterprise deployments, although purchasing processes are often evidence-intensive.

Arizona and Nevada offer strong growth because of population migration and aging demographics. Phoenix, Tucson, Las Vegas, and Reno are expanding specialty-care capacity, supporting demand for joint replacement, urology, general surgery, cancer care, and rehabilitation robotics. Health systems in these states can use robotic programs to attract retirees and differentiate new facilities.

Colorado and Utah have strong specialty hospitals, research networks, and integrated providers. Denver, Colorado Springs, Salt Lake City, and surrounding metropolitan areas support orthopedic, spine, neurosurgical, and general surgical robotics. Utah’s medtech and life-science ecosystem also supports technology development and clinician-industry collaboration.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets characterized by geographic dispersion and regional referral dependence. Robotics adoption is concentrated in major urban or tertiary centers. These states create opportunities for tele-mentoring, remote technical support, compact systems, and care models that reduce the need for patients to travel out of state.

The major regional constraint is affordability outside large urban systems. Vendors must demonstrate that advanced systems can operate reliably across dispersed facilities and limited specialist pools. Service responsiveness and uptime are particularly important where alternative systems or biomedical-engineering support are not locally available.

Northeast

The Northeast accounted for an estimated USD 1.79 billion in 2025 and is projected to reach approximately USD 7.03 billion by 2035. The region has a smaller population than the South but a high concentration of academic medical centers, specialist surgeons, complex procedures, clinical trials, and premium hospital technology.

New York is the largest state market in the Northeast. New York City contains major academic health systems and specialty programs across oncology, urology, gynecology, thoracic surgery, orthopedics, spine, and neurosurgery. Upstate markets in Buffalo, Rochester, Albany, and Syracuse add regional procedure volume. High operating costs and competitive physician markets encourage hospitals to invest in platforms that can improve recruitment and service-line positioning.

Pennsylvania provides a large and diverse market. Philadelphia and Pittsburgh contain influential academic centers, while central and northeastern Pennsylvania rely on regional health systems and community hospitals. The state supports strong demand for orthopedic, general surgery, urology, oncology, and rehabilitation robotics.

Massachusetts is one of the most influential states for clinical innovation despite its smaller population. Boston’s academic hospitals and research institutions frequently participate in early clinical evaluation, surgical data science, imaging integration, and robotics development. Procurement is rigorous and often requires strong evidence, cybersecurity review, and integration planning.

New Jersey and Connecticut have high population density, mature hospital networks, and access to major metropolitan referral markets. Hospitals compete with institutions in New York, Philadelphia, and Boston, encouraging investment in advanced robotic programs. New Jersey has significant demand in orthopedics, urology, gynecology, and cancer surgery, while Connecticut supports academic and community adoption.

Maine, New Hampshire, Vermont, and Rhode Island are smaller state markets. Robotic systems are concentrated in tertiary hospitals and major regional centers. Aging populations in northern New England support orthopedic and urologic demand, but lower population density can restrict system utilization. Shared clinical teams, multi-specialty deployment, and careful case-volume planning are essential.

The Northeast will remain a high-value market for new technology evaluation. It may grow more slowly than the West because of market maturity and slower population expansion, but its concentration of complex cases and influential clinicians gives it strategic importance disproportionate to its market size.

Midwest

The Midwest represented approximately USD 1.39 billion in 2025 and is projected to reach USD 4.83 billion by 2035. It offers a stable base of mature hospital systems, orthopedic procedure volume, academic centers, community hospitals, and medical-device expertise.

Illinois is the largest regional market, led by Chicago’s academic hospitals, integrated systems, cancer centers, and specialty surgical programs. The state supports strong demand across soft-tissue, orthopedic, spine, neurosurgical, and rehabilitation robotics. Downstate hospitals provide additional opportunities but require clear utilization plans.

Ohio has an influential network of academic and integrated providers in Cleveland, Columbus, and Cincinnati. The state is important for urology, cardiac and thoracic care, orthopedics, general surgery, and clinical research. The first commercial U.S. procedure using Medtronic’s Hugo system was performed in Ohio, illustrating the state’s importance in the adoption of competitive robotic platforms.

Minnesota combines major health systems with a deep medical-device ecosystem. Minneapolis–St. Paul and Rochester support advanced surgery, orthopedic care, cardiovascular programs, clinical research, and medical technology development. The state’s provider organizations often influence national clinical and procurement standards.

Michigan, Indiana, Wisconsin, and Missouri provide substantial procedure volumes across joint replacement, spine surgery, urology, gynecology, and general surgery. Detroit, Ann Arbor, Indianapolis, Milwaukee, Madison, Kansas City, and St. Louis are major adoption centers. Community hospitals in these states are increasingly evaluating robotics to prevent procedure leakage to metropolitan competitors.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller markets with strong regional referral patterns. Robotics is concentrated in academic hospitals, integrated networks, and high-volume orthopedic or general surgery centers. Rural geography creates challenges related to surgeon availability, capital utilization, service coverage, and patient travel.

The Midwest’s purchasing environment is generally value-conscious. Manufacturers that provide dependable service, strong clinical training, transparent disposable economics, and multi-procedure utilization are likely to outperform vendors relying primarily on technological novelty.

Key Market Players

The U.S. Medical Robotics Competitive Landscape is becoming more diversified but remains concentrated in several high-value categories. Intuitive Surgical retains the strongest position in multi-specialty soft-tissue robotic surgery because of its large installed base, established surgeon community, extensive instrument portfolio, and recurring procedure revenue.

Stryker is a leader in orthopedic robotics through the Mako ecosystem, supported by integration with joint-replacement implants and expansion into additional orthopedic and spine procedures. Medtronic competes across soft-tissue surgery, spine robotics, navigation, imaging, and digital operating-room technology. Its U.S. launch of the Hugo system introduces a significant new competitor into urologic robotic surgery.

Johnson & Johnson MedTech has entered a new competitive phase following U.S. market authorization for OTTAVA. The company can combine robotics with a broad surgical portfolio, energy devices, stapling, instruments, and hospital relationships. Zimmer Biomet and Smith+Nephew remain important orthopedic robotics competitors through integrated implant, planning, navigation, and robotic systems.

Globus Medical, Brainlab, and Medtronic are strategically important in spine and neurosurgical navigation and robotics. Accuray is a major participant in robotic radiosurgery, while Siemens Healthineers, through Corindus, operates in robotic vascular intervention. Stereotaxis focuses on robotic magnetic navigation for cardiac procedures.

PROCEPT BioRobotics has built a differentiated position in robotic waterjet therapy for benign prostatic hyperplasia. THINK Surgical participates in orthopedic robotics with open and implant-linked approaches. Monteris Medical, Renishaw, and Medical Microinstruments address specialized neurosurgical and microsurgical applications.

CMR Surgical, Distalmotion, Moon Surgical, Virtual Incision, and KARL STORZ through Asensus Surgical are expanding competition in compact, modular, digital, and outpatient-oriented soft-tissue robotics. Noah Medical is an important participant in robotic bronchoscopy. Ekso Bionics and Lifeward compete in rehabilitation and assistive exoskeleton technologies.

Some of the key players in the U.S. Medical Robotics industry are Intuitive Surgical, Stryker, Medtronic, Johnson & Johnson MedTech, Zimmer Biomet, Smith+Nephew, Globus Medical, Brainlab, Accuray, Siemens Healthineers through Corindus, Stereotaxis, PROCEPT BioRobotics, THINK Surgical, CMR Surgical, Distalmotion, Moon Surgical, Virtual Incision, KARL STORZ through Asensus Surgical, Noah Medical, Monteris Medical, Renishaw, Medical Microinstruments, Ekso Bionics, and Lifeward.

Competition during the forecast period will be influenced by FDA authorizations, indication breadth, surgeon training capacity, procedure economics, instrument reliability, system uptime, clinical evidence, artificial-intelligence integration, and commercial contracting flexibility. Market share will increasingly depend on the ability to develop a complete procedural ecosystem rather than a technically capable robot alone.

Recent Developments

Recent developments in the U.S. Medical Robotics Market show that the competitive environment is changing faster than at any previous stage of the industry. The market is moving from a largely single-platform soft-tissue structure toward multiple differentiated systems competing through architecture, footprint, sensing, financing, digital integration, and procedure specialization.

Intuitive Surgical received FDA clearance for its fifth-generation da Vinci 5 system in March 2024. The platform introduced enhanced computing, redesigned ergonomics, and force-feedback capabilities for selected uses. The company continued expanding system placements and procedure volumes through 2025 and the first half of 2026, maintaining the largest global installed base in robotic-assisted surgery.

Medtronic received FDA clearance for the Hugo robotic-assisted surgery system for urologic procedures in December 2025. Its cleared uses include prostatectomy, nephrectomy, and cystectomy. The first commercial U.S. Hugo procedure was completed at Cleveland Clinic in February 2026. Medtronic subsequently submitted filings intended to expand the system into general and gynecologic surgery.

CMR Surgical received FDA clearance for the Versius Plus system for adult cholecystectomy in December 2025 and began its U.S. commercial entry during 2026. The system’s modular architecture and compact design reflect increasing market interest in flexible systems that can operate across varied room configurations.

Distalmotion expanded the U.S. indications for its Dexter platform. Following authorization for inguinal hernia repair, the company received clearance for adult cholecystectomy and selected gynecologic procedures, including benign hysterectomy. Its commercial strategy emphasizes on-demand use and compatibility with outpatient surgical workflows.

Johnson & Johnson received U.S. market authorization for the OTTAVA robotic surgical system in July 2026. The company plans an initial commercial launch with selected U.S. customers while continuing clinical development for additional indications. OTTAVA introduces table-integrated robotic arms and is expected to become one of the most important new competitors in multi-specialty soft-tissue surgery.

Stryker continued expanding its Mako platform beyond established knee and hip applications. The development of Mako 4 and the addition of spine and shoulder capabilities strengthen its strategy of distributing robotic investment across a wider orthopedic procedure base.

Digital intelligence is also becoming a major development theme. Manufacturers are integrating procedural video, force data, workflow analytics, remote support, simulation, and real-time computing into their robotic ecosystems. The strategic objective is to transform the robot from a mechanical surgical tool into a connected operating-room platform capable of supporting training, performance analysis, and future decision assistance.

The competitive pipeline remains active. Emerging systems are being developed for microsurgery, endoluminal procedures, bronchoscopy, endoscopic intervention, neurosurgery, and compact abdominal surgery. Not every investigational platform will achieve broad commercialization, but the volume of development activity indicates that the next decade will support more specialized robotic categories and greater competition for hospital capital.

Conclusion

The U.S. Medical Robotics Market Size & Share is positioned to expand from approximately USD 8.15 billion in 2025 to USD 33.26 billion by 2035, supported by a CAGR of 15.10% during 2026–2035. Growth will be driven by minimally invasive surgery, aging demographics, rising procedural demand, hospital competition, orthopedic robotics, expanded soft-tissue platform choice, endoluminal intervention, digital operating-room integration, and recurring instrument and service revenue.

Soft-tissue surgical robots will remain the largest market component, but orthopedic and spine robotics, robotic bronchoscopy, microsurgery, rehabilitation systems, and assistive robotics will contribute increasing value. Instruments, accessories, software, and services are expected to grow faster than the installed system base because their revenue is linked to procedure utilization and long-term customer relationships.

The South will remain the largest regional market because of population scale, hospital expansion, demographic growth, and procedure demand. The West will record the fastest growth because of its innovation ecosystem, outpatient orientation, and early adoption of connected clinical technologies. The Northeast will remain important for complex procedures and evidence generation, while the Midwest will provide stable demand from mature hospital networks and high orthopedic procedure volumes.

The central strategic question for market participants is no longer whether robotics will become more common in U.S. healthcare. The more important questions are which systems can achieve sustainable utilization, which applications justify robotic economics, and which manufacturers can convert technological differentiation into repeatable clinical and operational value.

Hospitals will increasingly reject robotics programs built primarily around prestige. Capital approval will depend on a credible procedure pipeline, committed surgeons, efficient room workflows, predictable disposable costs, strong technical service, measurable outcomes, and a realistic pathway to positive contribution margin. Manufacturers that align clinical innovation with these procurement requirements will define the next phase of the U.S. medical robotics industry.

TABLE OF CONTENT

1. U.S. Medical Robotics Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Medical Robotics System Manufacturers
1.6.2. Robotic Components, Sensors, Actuators, and Contract Manufacturing Suppliers
1.6.3. Robotic Instruments, Accessories, and Consumables Suppliers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Academic Medical Centers and Specialty Surgical Centers
1.6.6. Ambulatory Surgery Centers
1.6.7. Rehabilitation Hospitals and Therapy Providers
1.6.8. Group Purchasing Organizations, Distributors, and Financing Partners
1.6.9. Payers, Regulators, Surgeons, and Clinical Decision-Makers

What this section provides: This section defines the U.S. medical robotics market boundary, study scope, research methodology, assumptions, and stakeholder ecosystem, allowing clients to understand how robotic systems, instruments, software, services, and procedure-linked revenues are measured and validated.

2. U.S. Medical Robotics Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size and CAGR Summary
2.8. High-Growth Opportunity Areas
2.9. Leading Product and Service Segments
2.10. Leading Clinical Application Segments
2.11. Regional Opportunity Summary
2.12. Competitive Intensity and Technology Adoption Summary

What this section provides: This section gives decision-makers a concise view of the U.S. medical robotics market size, growth trajectory, leading robotic applications, regional demand pockets, competitive intensity, and priority investment opportunities through 2035.

3. U.S. Medical Robotics Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Expansion of Minimally Invasive and Robotic-Assisted Surgery
3.1.2. Aging U.S. Population and Increasing Surgical Procedure Burden
3.1.3. Growth in Orthopedic Joint Replacement and Spine Procedures
3.1.4. Rising Adoption of Robotic Platforms in General Surgery, Urology, and Gynecology
3.1.5. Hospital Competition for Surgeons, Procedures, and Regional Referral Volumes
3.1.6. Expansion of Endoluminal, Bronchoscopic, and Interventional Robotics
3.1.7. Operating-Room Workforce Constraints and Workflow Standardization Needs
3.1.8. Growth in Recurring Robotic Instruments, Accessories, and Service Revenue
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Acquisition and Installation Costs
3.2.2. Recurring Instrument, Accessory, and Maintenance Expenses
3.2.3. Uncertain Utilization and Return on Investment at Low-Volume Facilities
3.2.4. Surgeon Training, Credentialing, and Learning-Curve Requirements
3.2.5. Operating-Room Setup, Docking, Turnover, and Workflow Complexity
3.2.6. Clinical Evidence and Comparative Outcomes Requirements
3.2.7. Cybersecurity, Software Reliability, and System Downtime Risks
3.3. Opportunities and Their Impact Analysis
3.3.1. Entry of New Soft-Tissue Robotic Surgery Platforms
3.3.2. Compact and Modular Robotic Systems for Ambulatory Surgery Centers
3.3.3. Artificial Intelligence-Enabled Surgical Analytics and Workflow Guidance
3.3.4. Force Feedback, Haptic Sensing, and Tissue-Interaction Analytics
3.3.5. Robotic Bronchoscopy and Endoluminal Intervention
3.3.6. Microsurgery and Robotic-Assisted Reconstructive Procedures
3.3.7. Rehabilitation Robotics and Assistive Exoskeletons
3.3.8. Hospital Pharmacy, Logistics, and Automation Robotics
3.3.9. Usage-Based, Leasing, Managed-Service, and Procedure-Based Commercial Models
3.4. Challenges and Their Impact Analysis
3.4.1. Establishing Sustainable Procedure Utilization
3.4.2. Demonstrating Superior Clinical and Economic Outcomes
3.4.3. Managing Multi-Vendor Robotic Fleets
3.4.4. Addressing Surgeon and Staff Resistance to Workflow Change
3.4.5. Achieving Interoperability with Imaging and Digital Operating-Room Systems
3.4.6. Protecting Patient and Procedural Data
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Robotic Procedure Contribution Margin Analysis
3.9. Installed-Base Utilization and Replacement-Cycle Analysis
3.10. Robotic System Total Cost of Ownership Analysis

What this section provides: This section evaluates the clinical, demographic, technological, economic, and operational forces shaping U.S. medical robotics demand, helping clients identify scalable growth opportunities and the principal barriers to successful robotic platform adoption.

4. U.S. Medical Robotics Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Robotic System Capital Pricing Analysis
4.5. Instruments, Accessories, and Consumables Pricing Analysis
4.6. Service, Maintenance, and Software Subscription Pricing Analysis
4.7. Value Chain & Supply Chain Analysis
4.8. Robotic Components and Critical Subsystem Supply Analysis
4.9. Impact of Digitalization and the Connected Operating Room
4.10. Artificial Intelligence and Surgical Data Ecosystem
4.11. Application & Innovation Landscape
4.12. FDA Regulatory Framework Analysis
4.13. CMS Reimbursement and Coverage Landscape
4.14. Robotic Procedure Coding and Payment Considerations
4.15. Import/Export Restrictions & Tariff Impact
4.16. Government Initiatives and Healthcare Automation Programs
4.17. Impact of Escalating Geopolitical Tensions
4.18. Cybersecurity and Software Lifecycle Requirements
4.19. Hospital Value Analysis Committee Decision Framework
4.20. Surgeon Training, Credentialing, and Clinical Adoption Framework
4.21. Environmental and Operating-Room Sustainability Considerations

What this section provides: This section gives clients a complete view of the regulatory, reimbursement, pricing, supply-chain, digital, competitive, and procurement environment affecting medical robotics commercialization and hospital adoption in the United States.

5. U.S. Medical Robotics Market – By Product and Service

5.1. Overview
5.1.1. Segment Share Analysis, By Product and Service, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
5.2. Robotic Systems and Platforms
5.2.1. Surgeon Consoles and Control Stations
5.2.2. Patient-Side Robotic Carts and Robotic Arms
5.2.3. Vision, Imaging, and Display Systems
5.2.4. Navigation and Procedure-Planning Workstations
5.2.5. Rehabilitation Robotic Systems
5.2.6. Assistive Robotic Systems and Exoskeletons
5.2.7. Hospital, Pharmacy, and Logistics Robots
5.3. Robotic Instruments and Accessories
5.3.1. Graspers, Forceps, and Needle Drivers
5.3.2. Scissors, Dissectors, and Cutting Instruments
5.3.3. Robotic Stapling Systems
5.3.4. Energy and Vessel-Sealing Instruments
5.3.5. Orthopedic Burs, Cutting Tools, and Tracking Arrays
5.3.6. Robotic Catheters, Scopes, Probes, and Biopsy Tools
5.3.7. Cannulas, Trocars, Drapes, and Sterile Accessories
5.3.8. Procedure-Specific Disposable Kits
5.4. Software and Digital Solutions
5.4.1. Surgical Planning Software
5.4.2. Robotic Navigation Software
5.4.3. Intraoperative Workflow Software
5.4.4. Surgical Video and Data Management Platforms
5.4.5. Artificial Intelligence-Enabled Analytics
5.4.6. Remote Monitoring and Predictive Maintenance Software
5.4.7. Simulation and Virtual Training Software
5.5. Maintenance and Technical Services
5.5.1. Preventive Maintenance
5.5.2. Repair and Field Technical Support
5.5.3. Software Updates and System Upgrades
5.5.4. Equipment Refurbishment and Replacement Services
5.5.5. Remote Diagnostics and Uptime Management
5.6. Training and Clinical Support Services
5.6.1. Surgeon Training and Simulation
5.6.2. Clinical Proctoring
5.6.3. Operating-Room Team Training
5.6.4. Credentialing and Competency Support
5.6.5. Robotic Program Development and Utilization Optimization

What this section provides: This section identifies the medical robotics products and services expected to generate the highest capital, recurring, software, and service revenue contributions through 2035.

6. U.S. Medical Robotics Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
6.2. General and Digestive Surgery
6.2.1. Hernia Repair
6.2.2. Colorectal Surgery
6.2.3. Bariatric Surgery
6.2.4. Cholecystectomy
6.2.5. Foregut Surgery
6.2.6. Hepatobiliary and Pancreatic Surgery
6.2.7. Other General Surgical Procedures
6.3. Urology and Gynecology
6.3.1. Prostatectomy
6.3.2. Partial and Radical Nephrectomy
6.3.3. Cystectomy
6.3.4. Endourology and Stone Management
6.3.5. Hysterectomy
6.3.6. Myomectomy
6.3.7. Sacrocolpopexy
6.3.8. Endometriosis and Other Gynecologic Procedures
6.4. Orthopedic and Spine Surgery
6.4.1. Total Knee Arthroplasty
6.4.2. Partial Knee Arthroplasty
6.4.3. Total Hip Arthroplasty
6.4.4. Shoulder Arthroplasty
6.4.5. Spinal Fusion and Screw Placement
6.4.6. Robotic Navigation and Musculoskeletal Planning
6.5. Neurosurgery and Robotic Radiosurgery
6.5.1. Stereotactic Biopsy
6.5.2. Deep Brain Stimulation Electrode Placement
6.5.3. Laser Ablation Procedures
6.5.4. Epilepsy Surgery
6.5.5. Intracranial and Extracranial Robotic Radiosurgery
6.5.6. Other Image-Guided Neurosurgical Procedures
6.6. Cardiothoracic, Endoluminal, and Interventional Procedures
6.6.1. Thoracic Surgery
6.6.2. Selected Cardiac Surgery Procedures
6.6.3. Robotic Bronchoscopy
6.6.4. Robotic Vascular and Endovascular Intervention
6.6.5. Robotic Catheter Navigation
6.6.6. Robotic Endoscopic and Natural-Orifice Procedures
6.7. Microsurgery and Reconstructive Surgery
6.7.1. Lymphatic Microsurgery
6.7.2. Microvascular Anastomosis
6.7.3. Reconstructive Surgery
6.7.4. Peripheral Nerve Procedures
6.8. Rehabilitation and Assistive Care
6.8.1. Gait Rehabilitation
6.8.2. Upper-Limb Rehabilitation
6.8.3. Stroke Rehabilitation
6.8.4. Spinal Cord Injury Rehabilitation
6.8.5. Exoskeleton-Assisted Mobility
6.8.6. Neurologic and Orthopedic Rehabilitation

What this section provides: This section helps clients identify the clinical applications driving robotic procedure volumes, recurring instrument demand, hospital capital investment, and the strongest opportunities for robotic platform expansion.

7. U.S. Medical Robotics Market – By Robotic Modality

7.1. Overview
7.1.1. Segment Share Analysis, By Robotic Modality, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
7.2. Soft-Tissue Surgical Robots
7.2.1. Multi-Port Robotic Systems
7.2.2. Single-Port Robotic Systems
7.2.3. Modular Robotic Systems
7.2.4. Table-Mounted and Table-Integrated Robotic Systems
7.2.5. Open-Console and Closed-Console Platforms
7.3. Orthopedic and Spine Robots
7.3.1. Joint Replacement Robotic Systems
7.3.2. Spine Robotic Systems
7.3.3. Robotic Bone Preparation Systems
7.3.4. Navigation-Integrated Orthopedic Robots
7.4. Endoluminal and Catheter-Based Robots
7.4.1. Robotic Bronchoscopy Systems
7.4.2. Robotic Endourology Systems
7.4.3. Robotic Vascular Intervention Systems
7.4.4. Robotic Cardiac Navigation Systems
7.4.5. Robotic Endoscopic Systems
7.5. Neurosurgical, Radiosurgical, and Microsurgical Robots
7.5.1. Stereotactic Neurosurgical Robots
7.5.2. Robotic Radiosurgery Systems
7.5.3. Robotic Laser-Ablation Guidance Systems
7.5.4. Microsurgical Robotic Platforms
7.6. Rehabilitation Robots and Exoskeletons
7.6.1. Lower-Limb Rehabilitation Robots
7.6.2. Upper-Limb Rehabilitation Robots
7.6.3. Stationary Gait-Training Systems
7.6.4. Wearable Medical Exoskeletons
7.7. Hospital, Pharmacy, and Logistics Robots
7.7.1. Pharmacy Compounding and Dispensing Robots
7.7.2. Autonomous Mobile Hospital Robots
7.7.3. Medication and Supply Transport Robots
7.7.4. Telepresence and Remote-Care Robots
7.7.5. Disinfection and Environmental-Service Robots

What this section provides: This section evaluates the principal robotic technology architectures used in U.S. healthcare and identifies which modalities are expected to achieve the strongest adoption, procedure penetration, and commercial scalability.

8. U.S. Medical Robotics Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
8.2. Hospitals and Integrated Health Systems
8.2.1. Large Integrated Delivery Networks
8.2.2. Community Hospitals
8.2.3. Regional Referral Hospitals
8.2.4. Government and Veterans’ Hospitals
8.3. Academic Medical Centers and Tertiary Referral Hospitals
8.3.1. Teaching Hospitals
8.3.2. Clinical Trial and Research Centers
8.3.3. Advanced Surgical Training Centers
8.4. Ambulatory Surgery Centers
8.4.1. Multi-Specialty Ambulatory Surgery Centers
8.4.2. Orthopedic and Spine Ambulatory Surgery Centers
8.4.3. Urology and Gynecology Ambulatory Surgery Centers
8.4.4. Hospital-Owned Outpatient Surgical Facilities
8.5. Specialty Hospitals and Dedicated Clinical Centers
8.5.1. Orthopedic Hospitals
8.5.2. Cancer Centers
8.5.3. Women’s Hospitals
8.5.4. Urology Centers
8.5.5. Spine and Neurosurgical Centers
8.6. Rehabilitation Hospitals and Therapy Providers
8.6.1. Inpatient Rehabilitation Facilities
8.6.2. Outpatient Rehabilitation Centers
8.6.3. Neurologic Rehabilitation Centers
8.6.4. Veterans’ and Long-Term Rehabilitation Providers
8.7. Pharmacies, Research Institutions, and Other Users
8.7.1. Hospital Pharmacies
8.7.2. Centralized Compounding Facilities
8.7.3. Universities and Research Laboratories
8.7.4. Medical Device Testing and Training Centers

What this section provides: This section explains which U.S. healthcare settings are driving robotic system purchases, procedural utilization, recurring service demand, and the migration of medical robotics into outpatient and rehabilitation environments.

9. U.S. Medical Robotics Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
9.2. Direct Hospital and Health System Procurement
9.2.1. Capital Purchase Agreements
9.2.2. Direct Instruments and Accessories Contracts
9.2.3. Service and Maintenance Agreements
9.3. Integrated Delivery Network Enterprise Contracts
9.3.1. Multi-Hospital System Standardization
9.3.2. Robotic Fleet Procurement Agreements
9.3.3. Enterprise Software and Data Agreements
9.3.4. Multi-Specialty Procedure Bundles
9.4. Group Purchasing Organization Contracts
9.4.1. GPO-Negotiated Capital Contracts
9.4.2. Instruments and Consumables Agreements
9.4.3. Service and Maintenance Contracting
9.5. Leasing, Managed-Service, and Usage-Based Models
9.5.1. Operating Leases
9.5.2. Capital Leases
9.5.3. Managed Equipment Services
9.5.4. Procedure-Based Payment Models
9.5.5. System Placement Agreements
9.6. Distributor and Specialty Supplier Sales
9.6.1. Regional Distribution
9.6.2. Rehabilitation Equipment Distribution
9.6.3. Pharmacy and Hospital Automation Distribution
9.7. Ambulatory and Specialty-Center Procurement
9.7.1. Independent Ambulatory Surgery Center Purchasing
9.7.2. Private Specialty Practice Procurement
9.7.3. Joint-Venture ASC Procurement
9.7.4. Refurbished and Pre-Owned Robotic System Purchasing

What this section provides: This section helps clients understand how medical robotic systems, instruments, software, and services are purchased in the United States, including hospital capital procurement, enterprise contracting, GPO influence, leasing, and outpatient financing models.

10. U.S. Medical Robotics Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Robotic Procedure Volume Analysis
10.1.4. Regional Hospital and Ambulatory Surgery Infrastructure Analysis
10.1.5. Regional Installed-Base and System Utilization Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Surgeon Density and Training Ecosystem
10.1.8. Regional Medical Technology Innovation and Investment Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Medical Robotics Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Medical Robotics Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Medical Robotics Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Medical Robotics Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product and Service, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Robotic Modality, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level medical robotics analysis, helping clients identify priority U.S. geographies, robotic procedure hubs, hospital capital-investment hotspots, outpatient adoption opportunities, and state-level commercial potential.

11. U.S. Medical Robotics Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.1.1. Market Share by Robotic System Revenue
11.1.2. Market Share by Instruments, Accessories, and Recurring Revenue
11.1.3. Market Share by Major Clinical Application
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking
11.3.1. Robotic Platform Architecture
11.3.2. FDA-Cleared Indication Breadth
11.3.3. Installed Base and Procedure Utilization
11.3.4. Instruments and Accessories Portfolio
11.3.5. Software and Artificial Intelligence Capabilities
11.3.6. Service, Training, and Commercial Model
11.3.7. Hospital and Ambulatory Surgery Center Positioning
11.4. Company Profiles
11.4.1. Intuitive Surgical
11.4.2. Stryker
11.4.3. Medtronic
11.4.4. Johnson & Johnson MedTech
11.4.5. Zimmer Biomet
11.4.6. Smith+Nephew
11.4.7. Globus Medical
11.4.8. Brainlab
11.4.9. Accuray
11.4.10. Siemens Healthineers – Corindus
11.4.11. Stereotaxis
11.4.12. PROCEPT BioRobotics
11.4.13. THINK Surgical
11.4.14. CMR Surgical
11.4.15. Distalmotion
11.4.16. Moon Surgical
11.4.17. Virtual Incision
11.4.18. KARL STORZ – Asensus Surgical
11.4.19. Noah Medical
11.4.20. Monteris Medical
11.4.21. Renishaw
11.4.22. Medical Microinstruments
11.4.23. Ekso Bionics
11.4.24. Lifeward
11.4.25. Vicarious Surgical

Note: Each company profile will include company overview, medical robotics portfolio, system architecture, clinical applications, U.S. commercialization strategy, installed-base positioning, financial performance, FDA and regulatory developments, clinical evidence, partnerships, acquisitions, pipeline activity, and recent strategic developments.

What this section provides: This section gives clients detailed competitor benchmarking, market-share visibility, platform positioning, recurring-revenue analysis, innovation direction, and strategic intelligence on established and emerging U.S. medical robotics companies.

12. U.S. Medical Robotics Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Artificial Intelligence-Enabled Surgical Intelligence
12.2.2. Force Feedback and Haptic Sensing
12.2.3. Single-Port and Reduced-Port Robotic Systems
12.2.4. Compact, Modular, and Ambulatory Robotic Platforms
12.2.5. Robotic Bronchoscopy and Endoluminal Intervention
12.2.6. Autonomous and Semi-Autonomous Procedural Assistance
12.2.7. Digital Twins and Patient-Specific Procedure Planning
12.2.8. Remote Collaboration, Tele-Mentoring, and Robotic Support
12.3. Emerging Business Trends
12.3.1. Platform-Based Procedure Ecosystems
12.3.2. Multi-Specialty Robotic Fleet Standardization
12.3.3. Growth of Usage-Based and Managed-Service Models
12.3.4. Expansion into Ambulatory Surgery Centers
12.3.5. Increased Competition in Soft-Tissue Robotics
12.3.6. Integration of Robotics with Imaging and Digital Operating Rooms
12.3.7. Growth in Surgical Data Monetization and Analytics
12.4. Business Opportunities for Startups and Existing Players
12.4.1. Specialized Robotic Instruments and Accessories
12.4.2. Robotic Workflow and Analytics Software
12.4.3. Microsurgery and Specialty Robotics
12.4.4. Rehabilitation and Assistive Robotics
12.4.5. Robotics-as-a-Service Business Models
12.4.6. Third-Party Training, Maintenance, and Fleet Optimization
12.5. Investment Prioritization Matrix
12.5.1. Market Attractiveness
12.5.2. Technology Readiness
12.5.3. Regulatory Risk
12.5.4. Commercial Scalability
12.5.5. Recurring Revenue Potential

What this section provides: This section prepares clients for future technology shifts, changing hospital purchasing behavior, competitive disruption, emerging commercial models, and investment opportunities across the U.S. medical robotics market through 2035.

13. U.S. Medical Robotics Market: Strategic Recommendations

13.1. Recommendations for Medical Robotics Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Ambulatory Surgery Centers
13.4. Recommendations for Academic and Specialty Medical Centers
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Clinical Evidence and Regulatory Strategy
13.10. Surgeon Training and Adoption Strategy
13.11. Product Positioning and Portfolio Expansion Guidance
13.12. Pricing, Leasing, and Managed-Service Strategy
13.13. Installed-Base Utilization and Customer Success Strategy
13.14. Instruments, Accessories, and Recurring Revenue Strategy
13.15. Ambulatory Surgery Center Market-Entry Strategy
13.16. Regional and State-Level Commercial Prioritization

What this section provides: This section converts market intelligence into actionable recommendations for product development, clinical adoption, capital procurement, commercial expansion, investment prioritization, recurring-revenue growth, and competitive differentiation.

14. U.S. Medical Robotics Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Market Estimation Limitation
14.5. Clinical and Regulatory Information Limitation
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer
14.8. Company and Product Information Disclaimer

What this section provides: This section clarifies the report’s scope, analytical limitations, forecasting assumptions, data-use terms, clinical and regulatory boundaries, and legal conditions.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Medical Robotics Market: Market Definition and Scope
TABLE 3: U.S. Medical Robotics Market: Research Methodology Framework
TABLE 4: U.S. Medical Robotics Market: Key Assumptions
TABLE 5: U.S. Medical Robotics Market: Market Ecosystem Overview
TABLE 6: U.S. Medical Robotics Market: Stakeholder Analysis
TABLE 7: U.S. Medical Robotics Market: Medical Robotics System Manufacturers and Supplier Ecosystem
TABLE 8: U.S. Medical Robotics Market: Hospital, ASC, Rehabilitation, Payer and Regulatory Stakeholder Matrix
TABLE 9: U.S. Medical Robotics Market: Executive Summary Snapshot, 2025
TABLE 10: U.S. Medical Robotics Market: Analyst Viewpoint Summary
TABLE 11: U.S. Medical Robotics Market: Market Attractiveness Index
TABLE 12: U.S. Medical Robotics Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 13: U.S. Medical Robotics Market: Base Year Market Positioning, 2025
TABLE 14: U.S. Medical Robotics Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 15: U.S. Medical Robotics Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 16: U.S. Medical Robotics Market: High-Growth Opportunity Areas
TABLE 17: U.S. Medical Robotics Market: Drivers; Impact Analysis
TABLE 18: U.S. Medical Robotics Market: Restraints; Impact Analysis
TABLE 19: U.S. Medical Robotics Market: Opportunities; Impact Analysis
TABLE 20: U.S. Medical Robotics Market: Challenges; Impact Analysis
TABLE 21: U.S. Medical Robotics Market: Patent & Innovation Analysis, 2021–2025
TABLE 22: U.S. Medical Robotics Market: Clinical Workflow Economics Matrix
TABLE 23: U.S. Medical Robotics Market: Hospital Capital Procurement Behavior Matrix
TABLE 24: U.S. Medical Robotics Market: Robotic Procedure Contribution Margin Analysis
TABLE 25: U.S. Medical Robotics Market: Installed-Base Utilization and Replacement-Cycle Analysis
TABLE 26: U.S. Medical Robotics Market: Robotic System Total Cost of Ownership Analysis
TABLE 27: U.S. Medical Robotics Market: PESTEL Analysis
TABLE 28: U.S. Medical Robotics Market: Porter’s Five Forces Analysis
TABLE 29: U.S. Medical Robotics Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 30: U.S. Medical Robotics Market: Robotic System Capital Pricing Analysis
TABLE 31: U.S. Medical Robotics Market: Instruments, Accessories and Consumables Pricing Analysis
TABLE 32: U.S. Medical Robotics Market: Service, Maintenance and Software Pricing Analysis
TABLE 33: U.S. Medical Robotics Market: Value Chain Analysis
TABLE 34: U.S. Medical Robotics Market: Supply Chain and Critical Component Analysis
TABLE 35: U.S. Medical Robotics Market: Connected Operating Room and Digitalization Impact
TABLE 36: U.S. Medical Robotics Market: Artificial Intelligence and Surgical Data Ecosystem
TABLE 37: U.S. Medical Robotics Market: Application & Innovation Landscape
TABLE 38: U.S. Medical Robotics Market: FDA Regulatory Framework Analysis
TABLE 39: U.S. Medical Robotics Market: CMS Reimbursement and Coverage Landscape
TABLE 40: U.S. Medical Robotics Market: Robotic Procedure Coding and Payment Considerations
TABLE 41: U.S. Medical Robotics Market: Import/Export Restrictions & Tariff Impact
TABLE 42: U.S. Medical Robotics Market: Government Initiatives and Healthcare Automation Programs
TABLE 43: U.S. Medical Robotics Market: Impact of Escalating Geopolitical Tensions
TABLE 44: U.S. Medical Robotics Market: Cybersecurity and Software Lifecycle Requirements
TABLE 45: U.S. Medical Robotics Market: Hospital Value Analysis Committee Decision Framework
TABLE 46: U.S. Medical Robotics Market: Surgeon Training, Credentialing and Adoption Framework
TABLE 47: U.S. Medical Robotics Market: Product and Service Snapshot, 2025
TABLE 48: Segment Dashboard; Definition and Scope, by Product and Service
TABLE 49: U.S. Medical Robotics Market, by Product and Service, 2021–2035 (US$ Billion)
TABLE 50: U.S. Medical Robotics Market: Segment Share Analysis, by Product and Service, 2025 & 2035 (%)
TABLE 51: U.S. Medical Robotics Market: Robotic Systems and Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Medical Robotics Market: Robotic Instruments and Accessories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Medical Robotics Market: Software and Digital Solutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Medical Robotics Market: Maintenance and Technical Services Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Medical Robotics Market: Training and Clinical Support Services Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Medical Robotics Market: Application Snapshot, 2025
TABLE 57: Segment Dashboard; Definition and Scope, by Application
TABLE 58: U.S. Medical Robotics Market, by Application, 2021–2035 (US$ Billion)
TABLE 59: U.S. Medical Robotics Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 60: U.S. Medical Robotics Market: General and Digestive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Medical Robotics Market: Urology and Gynecology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Medical Robotics Market: Orthopedic and Spine Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Medical Robotics Market: Neurosurgery and Robotic Radiosurgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Medical Robotics Market: Cardiothoracic, Endoluminal and Interventional Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Medical Robotics Market: Microsurgery and Reconstructive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Medical Robotics Market: Rehabilitation and Assistive Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Medical Robotics Market: Robotic Modality Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by Robotic Modality
TABLE 69: U.S. Medical Robotics Market, by Robotic Modality, 2021–2035 (US$ Billion)
TABLE 70: U.S. Medical Robotics Market: Segment Share Analysis, by Robotic Modality, 2025 & 2035 (%)
TABLE 71: U.S. Medical Robotics Market: Soft-Tissue Surgical Robots Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Medical Robotics Market: Orthopedic and Spine Robots Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Medical Robotics Market: Endoluminal and Catheter-Based Robots Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Medical Robotics Market: Neurosurgical, Radiosurgical and Microsurgical Robots Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Medical Robotics Market: Rehabilitation Robots and Exoskeletons Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Medical Robotics Market: Hospital, Pharmacy and Logistics Robots Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Medical Robotics Market: End User Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by End User
TABLE 79: U.S. Medical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 80: U.S. Medical Robotics Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 81: U.S. Medical Robotics Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Medical Robotics Market: Academic Medical Centers and Tertiary Referral Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Medical Robotics Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Medical Robotics Market: Specialty Hospitals and Dedicated Clinical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Medical Robotics Market: Rehabilitation Hospitals and Therapy Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Medical Robotics Market: Pharmacies, Research Institutions and Other Users Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Medical Robotics Market: Procurement Channel Snapshot, 2025
TABLE 88: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 89: U.S. Medical Robotics Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 90: U.S. Medical Robotics Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 91: U.S. Medical Robotics Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: U.S. Medical Robotics Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: U.S. Medical Robotics Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: U.S. Medical Robotics Market: Leasing, Managed-Service and Usage-Based Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: U.S. Medical Robotics Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: U.S. Medical Robotics Market: Ambulatory and Specialty-Center Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: U.S. Medical Robotics Market: Regional Snapshot, 2025
TABLE 98: Segment Dashboard; Definition and Scope, by Geography
TABLE 99: U.S. Medical Robotics Market, by Region, 2021–2035 (US$ Billion)
TABLE 100: U.S. Medical Robotics Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 101: West Region U.S. Medical Robotics Market: Regional Overview and Trends
TABLE 102: West Region U.S. Medical Robotics Market: Key Manufacturers and Procurement Ecosystem
TABLE 103: West Region U.S. Medical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 104: West Region U.S. Medical Robotics Market, by Product and Service, 2021–2035 (US$ Billion)
TABLE 105: West Region U.S. Medical Robotics Market, by Application, 2021–2035 (US$ Billion)
TABLE 106: West Region U.S. Medical Robotics Market, by Robotic Modality, 2021–2035 (US$ Billion)
TABLE 107: West Region U.S. Medical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 108: West Region U.S. Medical Robotics Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 109: California Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 110: Washington Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 111: Arizona Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 112: Colorado Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 113: Oregon Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 114: Utah Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 115: Nevada Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 116: New Mexico Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 117: Idaho Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 118: Montana Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 119: Wyoming Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 120: Alaska Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 121: Hawaii Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 122: Northeast Region U.S. Medical Robotics Market: Regional Overview and Trends
TABLE 123: Northeast Region U.S. Medical Robotics Market: Key Manufacturers and Procurement Ecosystem
TABLE 124: Northeast Region U.S. Medical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 125: Northeast Region U.S. Medical Robotics Market, by Product and Service, 2021–2035 (US$ Billion)
TABLE 126: Northeast Region U.S. Medical Robotics Market, by Application, 2021–2035 (US$ Billion)
TABLE 127: Northeast Region U.S. Medical Robotics Market, by Robotic Modality, 2021–2035 (US$ Billion)
TABLE 128: Northeast Region U.S. Medical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 129: Northeast Region U.S. Medical Robotics Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 130: New York Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 131: Massachusetts Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 132: New Jersey Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 133: Pennsylvania Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 134: Connecticut Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 135: Maine Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 136: Vermont Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 137: New Hampshire Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 138: Rhode Island Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 139: Delaware Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 140: South Region U.S. Medical Robotics Market: Regional Overview and Trends
TABLE 141: South Region U.S. Medical Robotics Market: Key Manufacturers and Procurement Ecosystem
TABLE 142: South Region U.S. Medical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 143: South Region U.S. Medical Robotics Market, by Product and Service, 2021–2035 (US$ Billion)
TABLE 144: South Region U.S. Medical Robotics Market, by Application, 2021–2035 (US$ Billion)
TABLE 145: South Region U.S. Medical Robotics Market, by Robotic Modality, 2021–2035 (US$ Billion)
TABLE 146: South Region U.S. Medical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 147: South Region U.S. Medical Robotics Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 148: Texas Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 149: Florida Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 150: Georgia Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 151: North Carolina Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 152: Tennessee Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 153: South Carolina Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 154: Alabama Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 155: Mississippi Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 156: Louisiana Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 157: Arkansas Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 158: Kentucky Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 159: Oklahoma Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 160: Virginia Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 161: Maryland Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 162: West Virginia Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 163: Midwest Region U.S. Medical Robotics Market: Regional Overview and Trends
TABLE 164: Midwest Region U.S. Medical Robotics Market: Key Manufacturers and Procurement Ecosystem
TABLE 165: Midwest Region U.S. Medical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 166: Midwest Region U.S. Medical Robotics Market, by Product and Service, 2021–2035 (US$ Billion)
TABLE 167: Midwest Region U.S. Medical Robotics Market, by Application, 2021–2035 (US$ Billion)
TABLE 168: Midwest Region U.S. Medical Robotics Market, by Robotic Modality, 2021–2035 (US$ Billion)
TABLE 169: Midwest Region U.S. Medical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 170: Midwest Region U.S. Medical Robotics Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 171: Illinois Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 172: Ohio Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 173: Michigan Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 174: Minnesota Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 175: Indiana Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 176: Wisconsin Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 177: Missouri Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 178: Iowa Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 179: Kansas Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 180: Nebraska Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 181: North Dakota Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 182: South Dakota Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 183: U.S. Medical Robotics Market: Competitive Landscape Snapshot, 2025
TABLE 184: U.S. Medical Robotics Market: Key Company Market Share Analysis, 2025
TABLE 185: U.S. Medical Robotics Market: Market Share by Robotic System Revenue, 2025
TABLE 186: U.S. Medical Robotics Market: Market Share by Instruments, Accessories and Recurring Revenue, 2025
TABLE 187: U.S. Medical Robotics Market: Company Positioning Matrix
TABLE 188: U.S. Medical Robotics Market: Robotic Platform and Product Portfolio Benchmarking
TABLE 189: U.S. Medical Robotics Market: FDA-Cleared Indication and Installed-Base Benchmarking
TABLE 190: U.S. Medical Robotics Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 191: Intuitive Surgical: Company Profile
TABLE 192: Stryker: Company Profile
TABLE 193: Medtronic: Company Profile
TABLE 194: Johnson & Johnson MedTech: Company Profile
TABLE 195: Zimmer Biomet: Company Profile
TABLE 196: Smith+Nephew: Company Profile
TABLE 197: Globus Medical: Company Profile
TABLE 198: Brainlab: Company Profile
TABLE 199: Accuray: Company Profile
TABLE 200: Siemens Healthineers – Corindus: Company Profile
TABLE 201: Stereotaxis: Company Profile
TABLE 202: PROCEPT BioRobotics: Company Profile
TABLE 203: THINK Surgical: Company Profile
TABLE 204: CMR Surgical: Company Profile
TABLE 205: Distalmotion: Company Profile
TABLE 206: Moon Surgical: Company Profile
TABLE 207: Virtual Incision: Company Profile
TABLE 208: KARL STORZ – Asensus Surgical: Company Profile
TABLE 209: Noah Medical: Company Profile
TABLE 210: Monteris Medical: Company Profile
TABLE 211: Renishaw: Company Profile
TABLE 212: Medical Microinstruments: Company Profile
TABLE 213: Ekso Bionics: Company Profile
TABLE 214: Lifeward: Company Profile
TABLE 215: Vicarious Surgical: Company Profile
TABLE 216: U.S. Medical Robotics Market: Future Market Scenario Analysis, 2026–2035
TABLE 217: U.S. Medical Robotics Market: Disruptive Technologies Impact Matrix
TABLE 218: U.S. Medical Robotics Market: Artificial Intelligence and Surgical Intelligence Roadmap
TABLE 219: U.S. Medical Robotics Market: Compact, Modular and Ambulatory Robotics Opportunity Map
TABLE 220: U.S. Medical Robotics Market: Endoluminal and Specialty Robotics Growth Roadmap
TABLE 221: U.S. Medical Robotics Market: Emerging Business Trends
TABLE 222: U.S. Medical Robotics Market: Business Opportunities for Startups and Existing Players
TABLE 223: U.S. Medical Robotics Market: Investment Prioritization Matrix
TABLE 224: U.S. Medical Robotics Market: Strategic Recommendations for Medical Robotics Manufacturers
TABLE 225: U.S. Medical Robotics Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 226: U.S. Medical Robotics Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 227: U.S. Medical Robotics Market: Strategic Recommendations for Academic and Specialty Medical Centers
TABLE 228: U.S. Medical Robotics Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 229: U.S. Medical Robotics Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 230: U.S. Medical Robotics Market: Strategic Recommendations for New Entrants and Startups
TABLE 231: U.S. Medical Robotics Market: Go-to-Market Strategy Considerations
TABLE 232: U.S. Medical Robotics Market: Clinical Evidence and Regulatory Strategy
TABLE 233: U.S. Medical Robotics Market: Surgeon Training and Adoption Strategy
TABLE 234: U.S. Medical Robotics Market: Product Positioning and Portfolio Expansion Guidance
TABLE 235: U.S. Medical Robotics Market: Pricing, Leasing and Managed-Service Strategy
TABLE 236: U.S. Medical Robotics Market: Installed-Base Utilization and Customer Success Strategy
TABLE 237: U.S. Medical Robotics Market: Regional and State-Level Commercial Prioritization
TABLE 238: U.S. Medical Robotics Market: Scope Limitation
TABLE 239: U.S. Medical Robotics Market: Data Use Limitation
TABLE 240: U.S. Medical Robotics Market: Forecasting Limitation
TABLE 241: U.S. Medical Robotics Market: Market Estimation Limitation
TABLE 242: U.S. Medical Robotics Market: Clinical and Regulatory Information Limitation
TABLE 243: U.S. Medical Robotics Market: Legal Disclaimer
TABLE 244: U.S. Medical Robotics Market: Third-Party Data Disclaimer
TABLE 245: U.S. Medical Robotics Market: Company and Product Information Disclaimer

List of Figures

FIGURE 1: U.S. Medical Robotics Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Medical Robotics Market Ecosystem
FIGURE 4: Stakeholder Ecosystem
FIGURE 5: Value Chain Analysis
FIGURE 6: Supply Chain Analysis
FIGURE 7: PESTEL Analysis
FIGURE 8: Porter’s Five Forces Analysis
FIGURE 9: Market Attractiveness Analysis
FIGURE 10: Market Dynamics
FIGURE 11: Innovation & Patent Landscape, 2021–2025
FIGURE 12: Clinical Workflow Economics Framework
FIGURE 13: Hospital Capital Procurement Decision Framework
FIGURE 14: Robotic System Total Cost of Ownership Framework
FIGURE 15: U.S. Medical Robotics Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 16: U.S. Medical Robotics Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 17: U.S. Medical Robotics Market Year-wise Growth Curve, 2021–2035
FIGURE 18: Product and Service Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Product and Service Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Robotic Systems and Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Robotic Instruments and Accessories Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Software and Digital Solutions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Maintenance and Technical Services Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Training and Clinical Support Services Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 26: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: General and Digestive Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Urology and Gynecology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Orthopedic and Spine Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Neurosurgery and Robotic Radiosurgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Cardiothoracic, Endoluminal and Interventional Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Microsurgery and Reconstructive Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Rehabilitation and Assistive Care Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Robotic Modality Segment Market Share Analysis, 2025 & 2035
FIGURE 35: Robotic Modality Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Soft-Tissue Surgical Robots Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Orthopedic and Spine Robots Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Endoluminal and Catheter-Based Robots Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Neurosurgical, Radiosurgical and Microsurgical Robots Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Rehabilitation Robots and Exoskeletons Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Hospital, Pharmacy and Logistics Robots Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 43: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Academic Medical Centers and Tertiary Referral Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Specialty Hospitals and Dedicated Clinical Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Rehabilitation Hospitals and Therapy Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Pharmacies, Research Institutions and Other Users Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Leasing, Managed-Service and Usage-Based Models Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Ambulatory and Specialty-Center Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 59: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Regional Robotic Procedure Volume and Installed-Base Comparison, 2025
FIGURE 61: Regional Hospital and Ambulatory Surgery Infrastructure Comparison, 2025
FIGURE 62: West Region U.S. Medical Robotics Market Share and Leading Players, 2025
FIGURE 63: West Region Market Share Analysis by State, 2025
FIGURE 64: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: California Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Washington Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Arizona Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Colorado Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Oregon Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Utah Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Nevada Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: New Mexico Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Idaho Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Montana Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Wyoming Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Alaska Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Hawaii Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Northeast Region U.S. Medical Robotics Market Share and Leading Players, 2025
FIGURE 79: Northeast Region Market Share Analysis by State, 2025
FIGURE 80: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: New York Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Massachusetts Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: New Jersey Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Pennsylvania Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Connecticut Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Maine Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Vermont Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: New Hampshire Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Rhode Island Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Delaware Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: South Region U.S. Medical Robotics Market Share and Leading Players, 2025
FIGURE 92: South Region Market Share Analysis by State, 2025
FIGURE 93: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Texas Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Florida Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Georgia Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: North Carolina Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Tennessee Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: South Carolina Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Alabama Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Mississippi Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Louisiana Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Arkansas Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Kentucky Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Oklahoma Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Virginia Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Maryland Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: West Virginia Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Midwest Region U.S. Medical Robotics Market Share and Leading Players, 2025
FIGURE 110: Midwest Region Market Share Analysis by State, 2025
FIGURE 111: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Illinois Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Ohio Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Michigan Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Minnesota Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Indiana Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Wisconsin Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Missouri Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Iowa Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Kansas Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: Nebraska Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: North Dakota Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: South Dakota Medical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 124: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 125: Company Positioning Matrix
FIGURE 126: Key Player Robotic Platform and Product Portfolio Benchmarking
FIGURE 127: FDA-Cleared Indication and Installed-Base Benchmarking
FIGURE 128: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 129: U.S. Medical Robotics Innovation Roadmap
FIGURE 130: Soft-Tissue Robotic Surgery Competitive Roadmap
FIGURE 131: Orthopedic and Spine Robotics Opportunity Map
FIGURE 132: Robotic Bronchoscopy and Endoluminal Robotics Growth Roadmap
FIGURE 133: Rehabilitation and Assistive Robotics Adoption Roadmap
FIGURE 134: Future Market Scenario Analysis, 2026–2035
FIGURE 135: Disruptive Technologies Impact Matrix
FIGURE 136: Artificial Intelligence and Surgical Intelligence Roadmap
FIGURE 137: Compact, Modular and Ambulatory Robotics Opportunity Map
FIGURE 138: Emerging Business Trends Matrix
FIGURE 139: Investment Prioritization Matrix
FIGURE 140: Strategic Growth Roadmap for U.S. Medical Robotics Companies
FIGURE 141: Go-to-Market Strategy Framework
FIGURE 142: Clinical Evidence and Regulatory Strategy Framework
FIGURE 143: Surgeon Training and Adoption Framework
FIGURE 144: Product Positioning and Portfolio Expansion Framework
FIGURE 145: Pricing, Leasing and Managed-Service Strategy Framework
FIGURE 146: Installed-Base Utilization and Customer Success Framework
FIGURE 147: Regional and State-Level Commercial Prioritization Map
FIGURE 148: Report Scope and Disclaimer Framework